Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3430
+0.02859.06%
Volume:1.80M
Turnover:588.84K
Market Cap:24.39M
PE:-1.00
High:0.3430
Open:0.3245
Low:0.3150
Close:0.3145
Loading ...
Mar 03, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2020

Major Issues Report

8-K - Current report
Dec 01, 2020

Major Issues Report

8-K - Current report
Nov 18, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report
Oct 22, 2020

Major Issues Report

8-K - Current report
Sep 30, 2020

Major Issues Report

8-K - Current report
Aug 26, 2020

Major Issues Report

8-K - Current report
Aug 25, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Jul 13, 2020

Major Issues Report

8-K - Current report